The arylhydrocarbon receptor (AhR) was initially identified as a member of the adaptive metabolic and toxic response pathway to polycyclic aromatic hydrocarbons and to halogenated dibenzo-p-dioxins and dibenzofurans. In the present study, we sought to determine the functional significance of the AhR pathway in pancreatic carcinogenesis. AhR expression was analysed by Northern blotting. The exact site of AhR expression was analysed by in situ hybridization and immunohistochemistry. The effects of TCDD and four selective AhR agonists on pancreatic cancer cell lines were investigated by growth assays, apoptosis assays, and induction of the cyclin-dependent kinase inhibitor p21. There was strong AhR mRNA expression in 14 out of 15 pancreatic cancer samples, weak expression in chronic pancreatitis tissues, and faint expression in all normal pancreata. In pancreatic cancer tissues, AhR mRNA and protein expression were localized in the cytoplasm of pancreatic cancer cells. TCDD and the four AhR agonists inhibited pancreatic cancer cell growth in a dose-dependent manner, and decreased anchorage-independent cell growth. DAPI staining did not reveal nuclear fragmentation and CYP1A1 and was not induced by TCDD and AhR agonists. In contrast, TCDD and AhR agonists induced the expression of the cyclindependent kinase inhibitor p21. In conclusion, the relatively non-toxic AhR agonists caused growth inhibition in pancreatic cancer cells with high AhR expression levels via cell cycle arrest. In addition, almost all human pancreatic cancer tissues expressed this receptor at high levels, suggesting that these or related compounds may play a role in the therapy of pancreatic cancer in the future.
Introduction
Adaptive metabolic responses to polycyclic aromatic compounds are achieved through induction of a number of CYP1A-dependent microsomal enzyme activities in the liver, collectively referred to as arylhydrocarbon hydroxylases (AHH) (Poland et al., 1974) . The arylhydrocarbon locus encodes for a highly polymorphic arylhydrocarbon receptor (AhR) (Denison et al., 1988) , which unbound is located in most cells in the cytoplasm as a complex containing heat shock protein 90 , an essential component of the AhR signaling pathway (Wu and Whitlock, 1992) . Ligand binding to the receptor causes a timedependent translocation of AhR into the nucleus, where it acts as a sequence-specific transcriptional regulator on specific dioxin-responsive enhancer elements as part of a heterodimeric complex with the AhR nuclear translocator (ARNT) protein (Elferink et al., 1990; Hoffman et al., 1991; Reyes et al., 1992) .
AhR agonists induce receptor-mediated up-regulation of xenobiotic metabolizing enzymes such as the cytochrome-P450 (CYP) 1A1-, 1A2-, and 1B1-dependent mono-oxygeneases, which contribute to AHH activity (Jones et al., 1986; Quattrochi et al., 1994) . Many environmental toxicants (Safe, 2001; Skene et al., 1989) such as polycyclic aromatic hydrocarbons, generated from incomplete pyrolysis of carbon sources, and halogenated aromatic hydrocarbons, which are formed during industrial chlorination processes and as byproducts of combustion, activate AhR. Halogenated aromatic hydrocarbons comprise three families of related compounds: polychlorinated dibenzo-p-dioxins (CDDs-75 congeners), polychlorinated dibenzofurans (CDFs-135 congeners) and polychlorinated biophenyls (PCBs-209 congeners), for which AhR is the primary mediator of their toxicity.
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a prototypical AhR agonist, causes embryotoxicity/ teratogenesis, immunosuppression, epithelial hyperplasia, metaplasia and tumor promotion in animals (Poland and Knutson, 1982) . TCDD has also been implicated in human tumorigenesis inasmuch as there is evidence that the AhR pathway is active in many human cancers (Angus et al., 1999; Cheung et al., 1999; Jana et al., 1999; Kashani et al., 1998; Ledirac et al., 2000; Li et al., 1998; Spink et al., 1998; Wang et al., 1992; Wormke et al., 2000) . However, TCDD itself is nongenotoxic since it does not covalently bind DNA, RNA or protein and is not mutagenic in the Ames assay (Geiger and Neal, 1981; Poland and Glover, 1979) . The possible mechanism of action seems to be the activation of metabolic pathways (cytochrome P450), DNA single strand breaks induced from lipid peroxidation products, and transcriptional regulation of cytokines and growth factors which results in altered cell proliferation (Huff et al., 1994) . Interestingly, AhR-mediated responses are antiproliferative in some cell types (Chen et al., 1998) and dietary administration of TCDD to Sprague-Dawley rats results in a decrease in several age-dependent spontaneous tumors, including mammary and uterine cancer (McDougal et al., 1997) . Thus, AhR might function as a potential target for selective AhR agonists, such as diindolylmethane (DIM) and alternate alkyl substituted chlorinated dibenzofurans (alkyl-PCDFs) in cancer treatment (Sun and . DIM is a major acid-catalyzed metabolite of indole-3-carbinol (I3C), a phytochemical component which is found in cruciferous vegetables and is reported to exhibit anti-carcinogenic activity (Kojima et al., 1994; Morse et al., 1990; Stoewsand et al., 1988; Wattenberg and Loub, 1978) . Alkyl-PCDFs, on the other hand, are synthetic selective AhR modulators that bind AhR and exhibit weak AhR agonist activity for several TCDD-like toxic responses. However, like TCDD, both DIM and alkyl-PCDFs exhibit antitumorigenic activity in vitro and in rodent mammary experimental tumor models (Chen et al., 1998; McDougal et al., 1997) .
Despite the relatively low incidence (9 -10 cases/ 100 000 population), pancreatic cancer (PCa) is one of the most frequent causes of cancer-related mortality in Western industrialized countries (Parker et al., 1997) . The reasons for its high mortality rate include difficulties with early diagnosis, rapid tumor progression following diagnosis, low resectability rates at the time of diagnosis, early tumor recurrence after resection and unresponsiveness to conventional treatments such as chemotherapy, radiotherapy or immunotherapy (Bu¨chler et al., 1991; Friess et al., 1992; Parker et al., 1997) . Currently, research is focused on molecular alterations that are likely to play a central role in the pathogenesis and subsequent evolution of PCa. Using microarray analysis of differentially expressed genes in the normal pancreas, chronic pancreatitis (CP), and PCa, we have previously identified AhR as a gene which is up-regulated in this malignancy in almost all tumors (unpublished observation). In the present study we sought to further determine the functional significance of the AhR pathway in pancreatic carcinogenesis, and the potential role of selective AhR modulators as new chemotherapeutic agents.
Results

AhR mRNA is overexpressed in human PCa
AhR mRNA expression was analysed in a panel of normal, CP and PCa tissues to quantify differences in expression of this receptor. AhR mRNA expression was very faint in the normal pancreas and was found in relatively low abundance in nine out of 15 (60%) CP tissue samples (Figure 1a) . In contrast, 14 out of 15 (93%) PCa samples exhibited moderate to high levels of AhR mRNA expression (Figure 1b) . There was no difference in AhR mRNA expression between early Figure 1 Northern blot analysis of AhR mRNA expression in normal chronic pancreatitis and pancreatic cancer tissue specimens and other tissues as indicated. AhR mRNA expression was of low abundance in CP tissue specimens (a) and strong in PCa tissue specimens (b). Densitometric analysis of the autoradiographs for quanitification and comparison of AhR mRNA expression showed that, in comparison with normal pancreatic tissues, there was an average 2.8-fold increase in AhR mRNA levels in the CP samples and an average 27-fold increase in PCa samples (P50.05) (c). AhR mRNA expression levels were very faint in normal esophagus, stomach, small bowel, liver, urinary bladder, and testis tissues, and moderate in normal colon tissues (d) tumor stages (stages I -II) and advanced tumor stages (stage III). Densitometric analysis of the autoradiographs for quantification and comparison of AhR mRNA expression in the normal pancreas with its expression in CP and PCa indicate that in comparison with normal pancreatic tissues, there was an average 2.8-fold increase in AhR mRNA levels in the CP samples and an average 27-fold increase in PCa samples (P50.05) (Figure 1c) .
AhR mRNA expression analysis in various other gastrointestinal organs was additionally done to determine whether the observed increase of AhR mRNA in pancreatic cancer was also present in normal tissue of other organs, e.g. of the gastrointestinal tract. This analysis revealed that AhR mRNA expression levels were very faint in normal esophagus, stomach, small bowel, and liver tissues, and moderate in normal colon tissues (Figure 1d ). The relatively low levels of AhR mRNA in the normal liver are somewhat surprising given the fact that AhR mRNA expression has been detected in the liver of various species (Carver et al., 1994; Roy and Wirgin, 1997; Takahashi et al., 1996) , including humans (Hayashi et al., 1994) . The low levels observed in the present study may be due to interindividual differences in liver AhR mRNA expression (Hayashi et al., 1994) , or due to the detection sensitivity of the method used.
AhR mRNA and protein is localized in PCa cells
In situ hybridization analysis was performed next in order to determine the exact site of AhR mRNA synthesis in the normal pancreas, CP and PCa tissues. In normal pancreatic tissue samples, very faint AhR in situ hybridization signals were observed in acinar and ductal cells (Figure 2a ). AhR in situ hybridization signals of faint to moderate intensity were present in the acinar and ductal cells in all the CP samples examined, and the strongest intensity of AhR mRNA expression was localized in metaplastic ductal cells of CP specimens (Figure 2b ). In contrast, AhR mRNA in situ hybridization signals were abundant in PCa samples. The signals were intense in the cancer cells forming ducts and duct-like structures (Figure 2c ,f). There were very faint or no AhR mRNA in situ hybridization signals in the connective tissue in areas adjacent to the cancer cells and in normal pancreatic tissue adjacent to tumor areas (not shown). Corresponding sense AhR in situ hybridization analysis revealed no specific signals (Figure 2d ,e).
Immunohistochemical analysis was performed next in normal, CP and PCa tissue samples to determine whether the enhanced mRNA synthesis is associated with increased AhR protein levels. AhR immunostaining was absent in the normal pancreatic tissue samples ( Figure 2g ) and faint to moderate in CP (Figure 2h,i) . In contrast, AhR immunoreactivity was intense in the PCa tissues (Figure 2j -l) . AhR was abundantly expressed in the cytoplasm of cancer cells within the pancreatic tumor mass and was absent in stromal elements adjacent to cancer cells (Figure 2l ). Western blot analysis confirmed the quantitative differences in AhR protein levels observed by immunohistochemistry (Figure 3 ). In the normal pancreas very faint signals were only visible in the original films. In contrast, all pancreatic cancer samples strongly exhibited the expected 110 kDA AhR protein band.
Cultured PCa cell lines express AhR and their growth is inhibited by AhR agonists
In the next experiments the functional role of AhR in PCa cell lines was investigated. AhR mRNA expression was first analysed in cultured PCa cell lines. Northern blot analysis in five PCa cell lines revealed relatively high expression levels of AhR mRNA in ASPC-1 and CAPAN-1 cells, moderate levels in T3M4 cells, and low levels in PANC-1 and Mia-PaCa-2 cells ( Figure 4) . Next, the effects of TCDD, three alkylPCDFs (6-MCDF, 8-MCDF, and 6-CHDF), and of DIM on PCa cell growth were studied. These experiments were carried out in two cell lines with high AhR mRNA expression levels (ASPC-1, CAPAN-1) and in two cell lines with low AhR expression levels (PANC-1, Mia-PaCa-2). In ASPC-1 cells, all three PCDF compounds exhibited dosedependent growth inhibition ( Figure 5 ). 6-CHDF was the most potent agent, with a 48 h growth inhibitory effect of 26, 43 and 99% at concentrations of 0.1, 1 and 10 mM, respectively. DIM was the least effective compound. Similar results were seen in CAPAN-1 cells, where all four compounds (alkyl-PCDFs and DIM) exhibited a potent dose-dependent growth inhibitory effect. In contrast, in MiaPaCa-2 cells all four compounds (alkyl-PCDFs and DIM) exhibited only a moderate cell growth inhibitory effect of 37 -70% when administered at a concentration of 10 mM. Notably, PANC-1 cells were relatively resistant (growth inhibitory effects of 6 -34% at a concentration of 10 mM) to all four compounds ( Figure 5 ). The in vitro growth inhibition properties of 6-MCDF, 8-MCDF, 6-CHDF and DIM in ASPC-1 and PANC-1 cell lines are shown in Figure 5 . Interestingly, TCDD exerted only slight dose-dependent growth inhibitory effects in all tested cell lines without a significant difference between the four cell lines ( Figure 6 ). In addition to anchorage cell growth, anchorage-independent cell growth properties of PCa cells treated with alkyl-PCDFs and DIM were also examined. In the tumorigenicity soft agar colony formation analysis, control cells displayed significantly increased anchorage-independent cell growth, with a high frequency of colony formation and larger colonies compared with cells treated with 1 mM alkyl-PCDFs or DIM ( Figure 7 and Table 1 ).
AhR agonists do not induce CYP1A1 in PCa cells
Alkyl-PCDFs and DIM, unlike most TCDD-like AhR agonists that induce several phase I cytochrome P450-dependent activities, are only weak inducers of CYP1A1 in cells and rodent liver. Therefore, CYP1A1 
AhR agonists do not induce apoptosis in PCa cells
In line with the previous observations, we tested whether cells treated with either alkyl-PCDFs or DIM at a concentration of 1 mM displayed morphological signs of apoptotic or necrotic cell death. Phase contrast microscopy did not reveal any signs of apoptotic or necrotic cell death such as cell shrinkage . Corresponding sense AhR in situ hybridization analysis revealed no specific signal (d, e). AhR immunostaining was absent in the normal pancreatic tissue samples (g) and faint to moderate in CP (h, i). PCa tissue specimens exhibited strong AhR immunostaining signals localized in the cancer cells within the tumor mass (j, k, l) or lysis, nuclear condensation, or increased detachment (data not shown). In addition, DAPI staining did not reveal chromatin condensation and/or nuclear fragmentation in cells treated with alkyl-PCDFs or DIM after 48, 72 and 96 h (data not shown).
AhR agonists induce cell cycle arrest via induction of CDK inhibitor p21
The observation that the investigated AhR agonists do not induce apoptosis prompted us to examine whether TCDD-like AhR activity leads to cell cycle arrest through induction of the cyclin-dependent kinsae inhibitor p21, thereby affecting cancer cell growth (Ma and Whitlock, 1996; Weiss et al., 1996) . The cyclin-dependent kinase inhibitor p21 was induced in ASPC-1 and CAPAN-1 cells treated with each of the alkyl-PCDFs or DIM. Maximal induction (3 -8-fold increase) was noticed after 2 -4 h. PANC-1 and MiaPaCa-2 cells also exhibited p21 induction after 2 -12 h, although to a lesser extent (maximum 2 -5-fold increase). Results of p21 induction in ASPC-1 and PANC-1 cells are shown in Figure 10 . TCDD itself also slightly induced p21 protein levels in pancreatic cancer cell lines, and maximal induction (2 -3-fold increase) was noticed after 2 -4 h ( Figure 9 ).
Discussion
TCDD displays high toxicity in animals, including acute and chronic toxic signs such as eye irritation, allergic dermatitis, nausea, vomiting, hyperpigmentation, metabolic and endocrine imbalance, hepatotoxicity, lymphoid depletion, immunosuppression, chloracne, poly-neuropathies, depressive syndromes, wasting syndrome and death (Buckingham and Macdonald, 1997; Dreisbach and Robertson, 1987; Goodman et al., 1990; Hayes, 1982 Poland and Knutson, 1982; Sax and Lewis, 1989; Sittig, 1985; Windholz et al., 1983) . TCDD also exhibits embryotoxicity/teratogenesis and induces epithelial hyperplasia, metaplasia and cancer (Poland and Knutson, 1982) . The toxic effects observed after TCDD exposure are likely mediated via the activation of the AhR pathway (Fernandez-Salguero et al., 1996; Landers and Bunce, 1991; Poland and Knutson, 1982) . In humans, TCDD exposure has been reported to be associated with a higher incidence of blood malignancies, soft tissue sarcomas, brain tumors, lung tumors, bladder and prostate tumors, and tumors in gastrointestinal sites, such as oropharyngeal, gastric, biliary and rectal cancer (Becher et al., 1996; Bertazzi et al., 1997 Bertazzi et al., , 2001 Fingerhut et al., 1991; Johnson, 1991; Krishnan et al., 1995; Rowlands et al., 1993; Steenland et al., 1999; Vickers et al., 1989; Wang et al., 1995) . However, other malignancies such as breast and endometrial cancer are decreased in exposed individuals (Bertazzi et al., 1997) . In the largest highly exposed industrial cohort mortality analysis, there were statistically significant positive linear trends in standardized mortality ratios, with increasing exposure to TCDD for all cancers combined (1.13, 95% confidence interval (CI) 1.02 -1.25), but interestingly not for PCa, which exhibited a slightly lower standardized mortality ratio (0.96, 95% CI 0.55 -1.56) (Steenland et al., 1999) . These observations suggest that activation of the AhR pathway results in different influences on tumor induction and behavior depending on the underlying organ. The AhR pathway is active in vitro in endometrial (Wormke et al., 2000) , liver (Ledirac et al., 2000) , breast (Angus et al., 1999; Spink et al., 1998) , prostate (Jana et al., 1999) , colon (Li et al., 1998) , cervical squamous (Wang et al., 1992) , and ovarian (Rowlands et al., 1993) cancer cell lines. Furthermore, enhanced AhR expression is present in kidney (Cheung et al., 1999) and prostatic (Kashani et al., 1998) tumor tissues. In our present study, we found consistently increased AhR mRNA expression levels in The heterodimer AhR-ARNT complex is proposed to be a transcriptional regulator of several inducible enzymes (Matsushita et al., 1993) that can accelerate the metabolism of planar lipophilic substances, including the polycyclic aromatic hydrocarbons, to active genotoxic metabolites (Hankinson, 1995; Swanson and Bradfield, 1993) and most TCDD-like toxic compounds induce several phase I cytochrome P450-dependent activities (Vang et al., 1990) . In the present study, we examined the response of cultured PCa cell lines to TCDD itself as well as to alkyl-PCDF and Figure 5 The in vitro effects of alkyl-PCDFs and DIM on pancreatic cancer cell growth: The SRB dye binding assay was used for the determination of the toxicity of 6-MCDF (a, e), 8-MCDF (b, f), 6-CHDF (c, g) and DIM (d, h) in adherent ASPC-1 (a -d) and PANC-1 (e -h) cell lines, as described in Materials and methods. In ASPC-1 cells, all three PCDF compounds exhibited dose-dependent growth inhibitory effects (a -c). 6-CHDF was the most potent agent (with growth inhibitory effects of 26, 43 and 99% at concentrations of 0.1, 1 and 10 mM, respectively), and DIM was the least effective compound. PANC-1 cells were relatively resistant to all four compounds. All experiments were performed in triplicate and results are presented as mean+standard error of mean (6+s.e.m.) DIM components, which are reported to exhibit anticarcinogenic activity in vitro and in experimental models of mammary tumors (Kojima et al., 1994; McDougal et al., 2001; Morse et al., 1990; Stoewsand et al., 1988; Wattenberg and Loub, 1978) . We Figure 6 The in vitro effects of TCDD on pancreatic cancer cell growth as described in Materials and methods. Cells were incubated with the indicated TCDD concentration (in mM) for 48 h. Cell lines are indicated on the left lower corner. All experiments were performed in triplicate and results are presented as mean+ standard error of mean (6+s.e.m.) Figure 7 Anchorage-independent cell growth properties of CAPAN-1 cells treated with 6-MCDF. In the tumorigenicity soft agar colony formation analysis, control cells displayed significantly increased anchorage-independent cell growth, with high frequency of colony formation and on average larger colonies compared with cells treated with 1 mM 6-MCDF (Vickers et al., 1989; . Thus, the activation of the AhR pathway may result in growth inhibition and reduced tumorigenicity in PCa cells, through mechanisms not readily apparent. However, there are several possible explanations for the growth inhibitory effects of AhR agonists, such as that the AhR-ARNT complex may interact with other growth regulatory systems. Furthermore, it is involved in the transcriptional activation of interleukin-1b and plasminogen activator inhibitor-2 as well as in the transcriptional repression of the glucocorticoid receptor, all of which have the potential to influence cell growth (Sakai et al., 1988; Sutter et al., 1991) and have been found to be activated in PCa (Norman et al., 1994; Takeuchi et al., 1993) . Additionally, an interaction between the nuclear AhR-ARNT complex and the Sp1 protein has been reported previously (Kobayashi et al., 1996; Wang et al., 1999) . Sp1 is a basal transcription factor that regulates gene expression and may subsequently modulate other DNA-bound transcription factors (RB, E2F1, GATA, p53, OTF, E1A, AP-1, EGR-1 and sterol regulatory element binding protein), including the glucocorticoid receptor and estrogen receptor (Patikoglou and Burley, 1997; Strahle et al., 1988) . Thus, the AhR pathway is linked through different multiple cross-talks with other cellular pathways, thereby critically influencing a variety of major cellular functions (Kuil et al., 1998; Ramamoorthy et al., 1999) .
Indeed, TCDD has been reported to modulate E2-induced pathways in human breast cancer cells through AhR nuclear complex interaction with inhibitory dioxin-responsive elements in the promoter regions of the responsible genes (Krishnan et al., 1994; Zacharewski et al., 1994) , and low-potency AhR agonists function as potent endocrine disruptors with antiestrogenic activity . Estrogen receptors and estrogen-binding proteins are also expressed in the normal human pancreas (AndrenSandberg et al., 1999) , and medroxyprogesterone inhibits the growth of PCa cell lines (ASPC-1, MiaPaCa-2) that express estrogen and progesterone receptors, indicating that the E2 pathway is activated in PCa (Abe et al., 2000) . Notably, in our study these two PCa cell lines also exhibited high AhR mRNA expression levels and cell growth inhibition upon treatment with selective AhR agonists. Furthermore, anchorage-independent cell growth was inhibited in all PCa cell lines by both groups of compounds (alkyl-PCDFs, DIM), irrespective of the AhR expression levels in these cells. These results suggest that there are different pathways leading to growth inhibition and reduced anchorage-independent growth. In addition, these results suggest that the inhibition of anchorage-independent growth might be mediated via AhR independent mechanisms. In this context, it has been shown recently that TCDD can inhibit the cell cycle checkpoint protein Mad2 via an AhR independent mechanism (Oikawa et al., 2001) . Therefore, the effects of alkyl-PCDFs and DIM may be due to their activities as selective AhR agonists and/or due to yet unknown AhR-independent mechanisms. For example, a recent study has shown that the alkyl-PCDF 6-MCDF inhibit mammary tumor growth in vivo at doses as low as 50 mg/kg, which suggest additional AhR independent effects since 6-MCDF displays only moderate binding affinity for the AhR (McDougal et al., 2001) . Although the exact mechanisms of the observed inhibition of anchorage-independent cell growth by both groups of compounds (alkyl-PCDFs, DIM) in all pancreatic cancer cell lines remain to be determined, the Figure 10 Induction of the cyclin-dependent kinase inhibitor p21 in ASPC-1 and PANC-1 cells treated with 1 mM alkyl-PCDFs or DIM for the indicated time as described in Materials and methods. p21 was induced in ASPC-1 cells after 2 -4 h treatment with either of the alkylPCDFs or DIM. PANC-1 cells treated with either alkyl-PCDFs or DIM exhibited p21 induction after 2 -12 h as well, although to a lesser extent. Western blots are representative of three separate experiments observed effects point to potentially therapeutic use of these compounds.
AhR is highly polymorphic (Dolwick et al., 1993) and exhibits species and tissue specificity, reflecting differences in response to environmental contaminants such as halogenated polycyclic aromatic hydrocarbons. This may explain the particular mediation of AhRmediated toxicity in some tissues only. As observed in our experiments, other normal tissues of the gastrointestinal tract, including the pancreas, exhibit very low levels of AhR expression. However, the increased expression of AhR mRNA in metaplastic ductal cells of CP as well as the non-significant difference in AhR mRNA expression between early and advanced PCa indicate that the AhR pathway is already activated early in the carcinogenetic process of PCa.
In our study we also examined whether an activated AhR pathway causes apoptosis and/or cell cycle arrest in PCa cells. Although the cyclin-dependent kinase inhibitor p21 was induced in PCa cells, apoptosis was not detected after exposure to alkyl-PCDFs or DIM. These data suggst that activation of the AhR pathway results in growth inhibition in PCa through cell cycle arrest but not cell death, and is in agreement with previous reports in which AhR was implicated in cell cycle G1 arrest (Ma and Whitlock, 1996; Weiss et al., 1996) through down-regulation of cyclins and cyclindependent kinases, and/or by induction of cyclindependent kinase inhibitors such as p21 (Cover et al., 1998; Kolluri et al., 1999; Rininger et al., 1997) .
In summary, our study shows that AhR expression is markedly increased with high frequency in PCa and that activation of the AhR pathway by non-toxic agonists results in growth inhibition in vitro through cell cycle arrest. Therefore, relatively non-toxic compounds activating the AhR pathway may ultimately have a potential role in the treatment of PCa and should be further evaluated in this disorder.
Materials and methods
Patients and tissue sampling
Fifteen PCa tissues were obtained from five male and 10 female patients (median age: 56.4 years; range: 44 -77). According to the Union Internationale Contre le Cancer (UICC) classification, there were four stage I, three stage II, and eight stage III adenocarcinomas. Fifteen chronic pancreatitis (CP) tissues were obtained from 11 male and four female patients (median age: 41.7 years; range: 33 -55 years). In addition, normal human tissue samples were obtained through an organ donor program from 13 previously healthy individuals (eight male donors, five female donors, median age: 47.5 years; range: 18 -69 years).
Freshly removed tissue samples were immediately fixed in 4% paraformaldehyde solution for 12 -24 h, and were subsequently paraffin-embedded for histological analysis. In addition, tissue samples destined for RNA extraction were snap-frozen in liquid nitrogen immediately upon surgical removal and maintained at 7808C until use. All studies were approved by the Human Subjects Committee at the University of Bern, Switzerland.
Probe synthesis
The AhR cDNA probe consisted of a 402 base pair fragment of human AhR cDNA (GenBank Accession number: NM-001621) that was subcloned into the pGEM-T-easy vector (Promega Biotechnology, Madison, WI, USA). A 190 base pair fragment of the mouse 7S cytoplasmic cDNA that crosshybridizes with human 7S RNA was used to verity equivalent RNA loading in the Northern blot experiments. For Northern blot blot analysis, cDNA probes (AhR, 7S) were labeled with a-32 P-dCTP, using a random primer labeling system (Roche Diagnostics, Rotkreuz, Switzerland). For in situ hybridization, cRNA probes of AhR were labeled with digoxigenin. After linearization, probes were transcribed using the Ribomax System (Promega Biotechnology), resulting in digoxigenin-labeled antisense and sense riboprobes specific for AhR mRNA.
Northern blot analysis
Total RNA was extracted by the guanidine isothiocyanate method, size fractionated on 1.2% agarose/1.8 M formaldehyde gels, and stained with ethidium bromide for verification of RNA integrity and loading equivalency. The RNA was capillary transferred onto nylon membranes and cross-linked by ultraviolet irradiation. Prehybridization, hybridization and washing was performed under conditions appropriate for cDNA probes, as previously reported in detail (Friess et al., 1993) . Membranes were then exposed at 7808C to Kodak Xray films using intensifying screens for 1 -7 days. All membranes were re-hybridized with the 7S cDNA probe to assess equivalent RNA loading, as previously reported (Friess et al., 1993) . Densitometric analysis of autoradiographs was performed using the Image Pro plus program. Relative AhR mRNA expression levels were calculated for each sample and the intensity of the AhR mRNA signal was normalized to the corresponding 7S signal.
In situ hybridization
Formalin-fixed, paraffin-embedded tissue sections (4 mm) were deparaffinized in xylene, hydrated in a graded series of ethanol to phosphate-buffered saline (PBS), acidified with 0.2 mol/l HCl for 20 min at room temperature (RT), rinsed in 26 standard saline citrate (SSC), digested with 30 mg/ml proteinase K (Roche Diagnostics, Rotkreuz, Switzerland) for 15 min at 378C, and post-fixed with 4% paraformaldehyde in PBS for 5 min at RT. Sections were then washed in 2% SSC, acetylated with 0.1 M triethanolamine-HCl (pH 8.0)/acetic anhydride for 10 min at RT, and washed again in 2% SSC. Sections were prehybridized for 1 h at 588C and incubated for 18 h at 588C with the digoxigenin-labeled RNA probe in hybridization buffer (50% formamide (v/v), 46SSC, 26Denhardt's reagent, and 500 mg RNA/ml, and 10% dextran sulfate (w/v). The concentration of the digoxigeninlabeled RNA probe was 500 ng/ml. After hybridization, excess probe was removed by washing with 26SSC and by RNAse treatment (40 U/ml RNAse T1) and 0.2 mg/ml RNAse (DNAse-free) (Roche Diagnostics, Rotkreuz, Switzerland) for 30 min at 378C. The sections were than washed in 26SSC for 20 min at 608C and finally in 0.26SSC for 20 min at 608C. Slides were then incubated with an alkaline phosphatase-conjugated anti-digoxigenin antibody (Roche Diagnostics, Rotkreuz, Switzerland). For color reaction, 5-bromo-4-chloro-3-indolyl phosphate toluidinum solution and nitro blue tetrazolium (Sigma, Buchs, Switzerland) were used.
Immunohistochemistry
Consecutive, paraffin-embedded tissue sections (4 mm) were deparaffinized and rehydrated, and antigen retrieval was performed by pretreatment of the slides in citrate buffer (pH 6) in a microwave oven (8 min at 850 W and another 10 min at 410 W). Thereafter, slides were cooled down to room temperature, placed in washing buffer solution (16Tris-buffer+BSA 0.1%) and subjected to immunostaining. Endogenous peroxidase activity was blocked by incubating the sections in methanol/0.6% hydrogen peroxide, followed by washing with TBS/0.1% BSA. After treatment with 10% normal rabbit serum, tissue sections were incubated overnight at 48C with the anti-AhR antibody (Santa Cruz, CA, USA). The sections were then incubated with anti-IgG biotinylated antibody and streptavidin-peroxidase complex, followed by incubation with 0.05% diaminobenzidine and counterstaining with Mayer's hematoxylin. Control slides, incubated without primary antibodies or with an unspecific IgG antibody, did not reveal any specific signal.
Western blot analysis
Proteins were extracted from approximately 200 mg tissue samples in a suspension buffer (10 mM Tris-HCl, pH 7.6, 100 mM NaCl) containing a protease inhibitor cocktail (Complete TM , mini, Roche Diagnostics, Rotkreuz, Switzerland). Protein extracts from normal and PCa tissue samples were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS -PAGE) on 7.5% gels and transferred to nitrocellulose filters by electroblotting. Unspecific binding was blocked by incubating the membranes in 5% non-fat milk in 20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween-20 (TBS-T). The membranes were incubated with the anti-AhR antibody (Santa Cruz, CA, USA) for 1 h at RT, then washed with TBS-T and incubated with a horseradish peroxidase conjugated rabbit anti-goat antibody (1:3000 dilution) (Biorad Laboratories, Hercules, CA, USA) for 1 h at RT. Antibody detection was performed with an enhanced chemiluminescence reaction (ECL Western blotting detection, Amersham Life Science, Amersham, UK). All experiments were performed in triplicate.
Chemicals and biochemicals for tissue culture experiments
Alkyl-PCDFs (6-Methyl-1,3,8-trichlorodibenzofuran (6-MCDF), 8-Methyl-1,3,6-trichlorodibenzofuran (8-MCDF) and 6-cyclo-hexyl-1,3,8-trichlorodibenzofuran (6-CHDF)), DIM and TCDD were prepared as described previously (Astroff and Harris et al., 1989) . Alkyl-PCDFs and DIM were stored in the dark to avoid photodecomposition. Anti-CYP1A1 antibodies were purchased from Chemicon International (Chemicon, CA, USA), and antiAhR, anti-p21 and anti-p27 antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Dimethysulfoxide (DMSO) was purchased from Fluka (Fluka, Buchs, Switzerland); sulforodamine B (SRB), 4,6-diamidino-2-phenylindole (DAPI) and all other chemicals were purchased from Sigma (Sigma, Buchs, Switzerland).
Cell cultures
ASPC-1, CAPAN-1, PANC-1 and MIA-PaCa-2 human PCa cell lines were obtained from American Type Culture Collection (ATCC, Rockville, MD, USA). T3M4 human PCa cell lines were a kind gift of Dr RS Metzgar (Duke University, Durham, NC, USA). Cells were grown in DMEM (PANC-1, MIA-PaCa-2) or RPMI (ASPC-1, CAPAN-1, T3M4) supplemented with 10% FCS, 100 U/ml penicillin, and 100 mg/ml streptomycin (complete medium). Cells were maintained at 378C in a humidified mixture of 5% CO 2 and 95% air.
The toxicity of alkyl-PCDFs (6-MCDF, 8-MCDF, 6-CHDF), DIM, and TCDD towards adherent cell lines was measured using the SRB dye binding assay (Skehan et al., 1990) . Briefly, cells were seeded at 5610 4 cells/well in 96-well plates in complete medium. After 24 h, the medium was changed and cells were treated with various concentrations of the compounds in appropriate cell-culture medium containing 1% FCS for 48, 72 and 96 h. DMSO 0.09% (v/v) was used as a vehicle for dissolving and delivering the compounds. DMSO was also used as a control. The medium was removed and the remaining adherent cells were fixed with ice-cold 10% trichloroacetic acid, air-dried, and stained with 0.4% SRB dissolved in 1% acetic acid. The excess dye was washed away, and the remaining bound SRB dye was extracted from the cells with 10 mmol/l Tris base. The absorbency of the dye was read at 540 nm using a plate reader (Dynatech MR 7000, Guernsey, Channel Islands, UK). All experiments were performed in triplicate.
For determination of anchorage-independent cell growth, soft agar analysis was performed. 2610 3 cells, in twofoldconcentration DMEM or RPMI containing 20% FCS and DMSO (control), or 6-MCDF, 8-MCDF, 6-CHDF and DIM, respectively, were mixed with an equal volume of 0.7% agarose and poured onto a bed of 0.6% agarose. After 15 days, colonies were measured and those larger than 200 mm were counted under the microscope. All experiments were performed in triplicate.
For induction experiments, 1610 5 cells/ml were seeded in 6-well plates in complete medium. After 24 h, the indicated compounds diluted in DMSO were added directly to the appropriate growth media, containing 1% FCS. Cells were incubated for 0, 2, 4, 12, 24 and 48 h. Thereafter, cells were washed with ice-cold phosphate-buffered saline (PBS) and solubilized in cell lysis buffer containing 50 mM Tris (pH 7.5), 150 mM NaCl. 2 mM EDTA, 0.1% SDS and complete protease inhibitor tablets (Complete TM , mini, Roche Diagnostics, Rotkreuz, Switzerland). Cell lysates were then subjected to Western blot analysis for CYP1A1 and p21.
Apoptosis assays
For assay of apoptosis, 1610 5 cells/ml were seeded in 6-well plates in complete medium. Twenty-four hours after seeding, growth medium was replaced with fresh appropriate cellculture medium containing 1% FCS and the indicated compounds diluted in DMSO. After 48 h of treatment, cells were trypsinized, pelleted, resuspended in PBS, fixed in 3.7% paraformaldehyde/PBS for 15 min, stained for 15 min with DAPI at a concentration of 1 mg/ml, washed again in PBS, pelleted and resuspended in 5 -20 ml of PBS. Coverslips were mounted on glass slides with Mowiol and analysed via fluorescence microscopy.
Statistical analysis
Results are expressed as mean+standard error of mean (s.e.m.) or standard deviation (s.d.). For statistical analysis of Mann-Whitney U-test was used. Significance was defined as P50.05. Abbreviations AHH, arylhydrocarbon hydroxylases; AhR, arylhydrocarbon receptor; Alkyl-PCDFs, alkyl substituted chlorinated dibenzofurans; ARNT, AhR nuclear translocator protein; CYP1A1, cytochrome-P450 1A1; DIM, diindolymethane; TCDD, 2, 3, 7, 3, 3, 3, 
